CIK 0001434316 · Non-accelerated filer<br>Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 651311552
- Phone
- 858.875.1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 2,447 shares at $7.77 ($19,013)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 1,849 shares at $5.00 ($9,245)
- 4 Open-market sale General Counsel and Secretary sold 10,874 shares at $4.37 ($47,519)
- 4 Open-market sale Chief R&D Officer sold 11,271 shares at $4.38 ($49,367)
- 4 Open-market sale President and CEO sold 14,391 shares at $4.37 ($62,889)
- 4 Open-market sale Chief Financial Officer sold 7,028 shares at $4.37 ($30,712)
- 4 Planned sale Chief Financial Officer sold 5,182 shares at $3.66 ($18,966)
- 4 Open-market buy Director bought 44,630 shares at $3.72 ($166,024)
- 4 Planned sale Chief Financial Officer sold 1,585 shares at $3.50 ($5,548)
- 4 Planned sale General Counsel and Secretary sold 24,363 shares at $2.40 ($58,471)
- 4 Open-market sale Chief Financial Officer sold 4,718 shares at $2.80 ($13,210)
Page 4 of 21 · 403 filings